Vertex Pharma gains 1.55 percent after-hours to EUR 453.03
Published on 10/07/2026 at 20:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Vertex Pharma traded at EUR 453.03 after-hours at 8:38 p.m. CEST on October 7, 2026, up plus 1.55 percent versus the prior close at Lang & Schwarz.
After-hours trading
The previous Lang & Schwarz close was EUR 446.10 on October 6, 2026. The bid was EUR 452.95 and the ask was EUR 453.10. On the primary exchange, Vertex Pharmaceuticals common stock trades under the ticker VRTX on the Nasdaq Global Select Market. The Nasdaq close was USD 502.31 on October 6, 2026, according to Forbes. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CEST is shown by the continuously updated real-time quote of Vertex Pharma stock.
Quarterly figures in context
For the quarter ended June 30, 2026, Vertex Pharmaceuticals Incorporated reported total revenue of USD 3,333.9 million, net income of USD 1,099.8 million and diluted earnings per share of USD 4.31 in its U.S. GAAP Form 10-Q filed with the SEC.
Forbes listed Vertex’s 52-week range as USD 402.58 to USD 560.25 and its market capitalization as USD 127.32 billion.
